Webinar replay

Calculating Risk and Return in Oncology Development

In this session, we investigate macro trends and forecasts in oncology using proprietary Evaluate Pharma and Evaluate Omnium metrics, and offer perspectives from our work on the best frameworks and methodologies to quantify risk and return in highly dynamic oncology markets.

Watch this replay to get expert insights from our panelists:
Paul Verdin
Dr. Paul Verdin
Head of Custom Solutions
Evaluate
Henry Barling-v2
Henry Barling
Senior Oncology Analyst
Evaluate

Watch the recording

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.